| 1 |
Chu XQ, Wang J, Chen GX, Zhang GQ, Zhang DY, Cai YY. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis. Pathol Res Pract 2018;214:151-62. [PMID: 29129493 DOI: 10.1016/j.prp.2017.10.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 2 |
Bottini N, Peterson EJ. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu Rev Immunol. 2014;32:83-119. [PMID: 24364806 DOI: 10.1146/annurev-immunol-032713-120249] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 3 |
Budding K, van Setten J, van de Graaf EA, van Rossum OA, Kardol-Hoefnagel T, Kwakkel-van Erp JM, Oudijk ED, Hack CE, Otten HG. The Autoimmune-Associated Single Nucleotide Polymorphism Within PTPN22 Correlates With Clinical Outcome After Lung Transplantation. Front Immunol 2018;9:3105. [PMID: 30705675 DOI: 10.3389/fimmu.2018.03105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Chen Z, Lu Y, Wu J, Zhang H. Clinical significance of blood platelets and mean platelet volume in patients with ulcerative colitis. J Int Med Res 2021;49:3000605211009715. [PMID: 33884913 DOI: 10.1177/03000605211009715] [Reference Citation Analysis]
|
| 5 |
Castro-Sanchez P, Teagle AR, Prade S, Zamoyska R. Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy. Front Cell Dev Biol 2020;8:608747. [PMID: 33425916 DOI: 10.3389/fcell.2020.608747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Soto ME, Montufar-Robles I, Jiménez-Morales S, Gamboa R, Huesca-Gómez C, Ramírez-Bello J. An association study in PTPN22 suggests that is a risk factor to Takayasu's arteritis. Inflamm Res 2019;68:195-201. [PMID: 30470857 DOI: 10.1007/s00011-018-1204-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Mustelin T, Bottini N, Stanford SM. The Contribution of PTPN22 to Rheumatic Disease. Arthritis Rheumatol 2019;71:486-95. [PMID: 30507064 DOI: 10.1002/art.40790] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 8 |
Dullin R, Koch M, Sterneck M, Nashan B, Thude H. Association between a gain-of-function variant of PTPN22 and rejection in liver transplantation. Transplantation 2015;99:431-7. [PMID: 25073032 DOI: 10.1097/TP.0000000000000313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Ferjeni Z, Bouzid D, Fourati H, Stayoussef M, Abida O, Kammoun T, Hachicha M, Penha-Gonçalves C, Masmoudi H. Association of TCR/CD3, PTPN22, CD28 and ZAP70 gene polymorphisms with type 1 diabetes risk in Tunisian population: family based association study. Immunol Lett 2015;163:1-7. [PMID: 25448703 DOI: 10.1016/j.imlet.2014.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 10 |
Remuzgo-Martínez S, Genre F, Castañeda S, Corrales A, Moreno-Fresneda P, Ubilla B, Mijares V, Portilla V, González-Vela J, Pina T, Ocejo-Vinyals G, Irure-Ventura J, Blanco R, Martín J, Llorca J, López-Mejías R, González-Gay MA. Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis. Sci Rep 2017;7:10525. [PMID: 28874816 DOI: 10.1038/s41598-017-10915-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 11 |
Thude H, Tiede P, Marget M, Peine S, Nashan B, Koch M. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene polymorphisms in liver transplant donors and impact on acute cellular liver transplant rejection. HLA 2020;95:40-4. [PMID: 31577847 DOI: 10.1111/tan.13706] [Reference Citation Analysis]
|
| 12 |
Ramírez-Pérez S, Sánchez-Zuno GA, Chavarría-Buenrostro LE, Montoya-Buelna M, Reyes-Pérez IV, Ramírez-Dueñas MG, Palafox-Sánchez CA, Martínez-Bonilla GE, Muñoz-Valle JF. PTPN22 +788 G>A (R263Q) Polymorphism is Associated with mRNA Expression but it is not a Susceptibility Marker for Rheumatoid Arthritis Patients from Western Mexico. Biochem Genet 2019;57:455-65. [PMID: 30637604 DOI: 10.1007/s10528-019-09902-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 13 |
Norén E, Almer S, Söderman J. Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease. BMC Gastroenterol 2017;17:68. [PMID: 28545409 DOI: 10.1186/s12876-017-0620-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Li F, Li N, Zhu Q, Zhou Z, Zhang P, Yang C, Han Q, Lv Y, Wei P, Liu Z. Association of PTPN22 gene polymorphisms with chronic hepatitis B virus infection in Chinese Han population. Hum Immunol 2015;76:736-41. [PMID: 26429315 DOI: 10.1016/j.humimm.2015.09.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 15 |
Hedjoudje A, Cheurfa C, Briquez C, Zhang A, Koch S, Vuitton L. rs2476601 polymorphism in PTPN22 is associated with Crohn's disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls. Ann Gastroenterol 2017;30:197-208. [PMID: 28243041 DOI: 10.20524/aog.2017.0121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
